The recommended initial dose is 30,000 IU per week (corresponding to approximately 450 IU/ kg body weight per week, based on an average weighted patient).
Soovitatav algannus on 30 000 RÜ nädalas (vastab ligikaudu 450 RÜ/ kg kehakaalu kohta nädalas, mis põhineb keskmise kehakaaluga patsiendil).